1. DOP04 Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn's Disease. (30th January 2023) Authors: Hornsby, E; Gadhok, R; Yadon, A N; Lindsay, J O; Stagg, A J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP23 Single-cell RNA sequencing identifies an important role for class I histone-deacetylase enzymes in intestinal myofibroblasts from patients with Crohn's Disease strictures. (27th May 2021) Authors: Lewis, A; Pan-Castillo, B; Berti, G; Felice, C; Gordon, H; Gadhok, R; Minicozzi, A; Chinaleong, J; Feakins, R; Lindsay, J; Silver, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P100 Successful eradication of respiratory tract MRSA in cystic fibrosis: a retrospective study. (14th November 2013) Authors: Green, H; Gadhok, R; Alshafi, K; Bilton, D; Simmonds, NJ Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P231 CPR and Ventilation Preferences in COPD Patients Using Home NIV: Still Unexplored After Ten Years. (19th November 2012) Authors: Dickson, JL; Gadhok, R; Hind, MD; Simonds, AK; Polkey, MI Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P318 Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort. (25th January 2019) Authors: Gadhok, R; Rao, R; Honap, S; Samaan, M; Harpham-Lockyer, L; Kwok, H; Whitley, L; Ibarra, A; Burgess, N; Seward, E; Parkes, G; Mehta, S; Vega, R; McCartney, S; Bloom, S; Irving, P; Lindsay, J O; Kok, K; Rahman, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P584 Systematic Review and Meta-analysis Evaluating the Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease. (21st January 2022) Authors: Hosack, T; Gadhok, R; Lindsay, J O Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P616 Ustekinumab for refractory paediatric Crohn's disease: experience from two UK tertiary referral centres. (25th January 2019) Authors: Rao, R; Gadhok, R; Whitley, L; Burgess, N; Amon, P; Naik, S; Lindsay, J; McCartney, S; Kok, K Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P689 UK Asians are prescribed vedolizumab earlier in disease history than Caucasians, but respond equally well to therapy. (16th January 2018) Authors: Gordon, H; Gadhok, R; Ibarra, A; Lindsay, J O Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PTH-084 Ustekinumab: Early experience and medium-term outcomes from a UK multi-centre real-world cohort. (June 2019) Authors: Gadhok, R; Rao, R; Honap, S; Samaan, M; Harpham-Lockyer, L; Kwok, H; Whitley, L; Ibarra, A; Burgess, N; Seward, E; Parkes, G; Mehta, S; Vega, R; McCartney, S; Bloom, S; Irving, P; Lindsay, JO; Kok, K; Rahman, F Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PTH-098 Anti-tnfs more frequently stopped due to loss of response in british asians with crohn's disease: a single centre retrospective analysis. (17th June 2017) Authors: Gadhok, R; Gordon, H; Sebepos-Rogers, G; Baillie, S; Akbar, S; Ahmad, OF; Cooper, B; Lindsay, JO Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗